Copyright
©The Author(s) 2024.
World J Transplant. Jun 18, 2024; 14(2): 93567
Published online Jun 18, 2024. doi: 10.5500/wjt.v14.i2.93567
Published online Jun 18, 2024. doi: 10.5500/wjt.v14.i2.93567
Heart transplant recipients | Total (n = 98) | MDRO presence (n = 32) | MDRO-free (n = 66) | P value |
Demographics | ||||
Age (yr) | 50 (37-56) | 51 (41-56) | 45.5 (35.5-56) | 0.48 |
Sex (male) | 69 (70.4) | 25 (78.1) | 44 (66.7) | 0.24 |
Height (cm), SD | 172 (9) | 174 (8) | 172 (9) | 0.25 |
Body weight (kg), SD | 75 (15) | 81 (11) | 72 (16) | 0.002 |
ΒΜΙ (kg/m2), SD | 25.1 (3.8) | 26.9 (3) | 24.3 (3.9) | 0.001 |
Heart failure etiology | ||||
Non-ischemic cardiomyopathy | 75 (76.5) | 23 (71.9) | 52 (78.8) | 0.45 |
Ischemic cardiomyopathy | 22 (22.4) | 8 (25) | 14 (21.2) | 0.67 |
Comorbidities | ||||
Diabetes mellitus | 21 (21.4) | 8 (25) | 13 (19.7) | 0.54 |
CRF (eGFR ≤ 60 mL/min/m2) | 13 (13.3) | 8 (25) | 5 (7.6) | 0.017 |
Vasculopathy | 40 (40.8) | 17 (53.1) | 23 (34.8) | 0.08 |
COPD | 5 (5.1) | 2 (6.3) | 3 (4.5) | 0.72 |
Previous cardiac surgery | 18 (18.4) | 24 (75) | 38 (57.6) | 0.09 |
Smoking history | 55 (56.7) | 21 (65.6) | 34 (52.3) | 0.21 |
Status at transplantation | ||||
VAD | 54 (55.1) | 22 (68.8) | 32 (48.5) | 0.06 |
Admitted from home | 65 (66.3) | 20 (62.5) | 45 (68.2) | 0.10 |
Admitted from ward | 15 (15.3) | 5 (15.6) | 10 (15.2) | 0.95 |
Admitted from ICU | 18 (18.4) | 7 (21.9) | 11 (16.7) | 0.53 |
Operating room | ||||
General anesthesia (hours) | 7 (6-8) | 6.5 (6-8) | 7 (6-8) | 0.84 |
Extracorporeal circulation (min) | 168 (144-229) | 210 (146-271) | 161 (141-193) | 0.003 |
Aorta closure (min) | 115 (77-198) | 115 (85-130) | 115 (67-211) | 0.94 |
Transfusion (RBC units) | 4 (2-10) | 9.5 (4-13) | 4 (2-7) | 0.001 |
Post transplantation | ||||
Primary graft dysfunction | 13 (13.3) | 10 (31) | 3 (4.5) | 0.001 |
Surgical re-exploration | 20 (20.4) | 11 (34) | 9 (13.6) | 0.017 |
Ventilator days | 2 (1-5) | 5 (3-3.5) | 1.3 (1-3) | 0.001 |
NO for refractory hypoxemia | 25 (25.5) | 14 (43.8) | 11 (16.7) | 0.04 |
CRRT for renal failure | 15 (15.3) | 9 (28) | 6 (9) | 0.014 |
Post Tx mechanical circulatory support | 32 (32.7) | 15 (46.9) | 17 (25.8) | 0.037 |
ATG treatment (days) | 5 (4-7) | 6 (5-8) | 5 (4-6) | 0.08 |
Outcomes | ||||
ICU stay, days | 10 (7-17) | 15.5 (10-26) | 9 (7-12) | 0.001 |
Post transplantation total hospital stay, days | 30 (24-41) | 38 (25-62) | 28 (21-39) | 0.006 |
Early mortality (30 d) | 9 (1) | 6 (18.8) | 3 (4.5) | 0.02 |
Late mortality (1-year) | 14 (14.3) | 9 (28.1) | 5 (7.6) | 0.006 |
Died in ICU | 12 (12.2) | 8 (25) | 4 (6) | 0.003 |
- Citation: Hatzianastasiou S, Vlachos P, Stravopodis G, Elaiopoulos D, Koukousli A, Papaparaskevas J, Chamogeorgakis T, Papadopoulos K, Soulele T, Chilidou D, Kolovou K, Gkouziouta A, Bonios M, Adamopoulos S, Dimopoulos S. Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation. World J Transplant 2024; 14(2): 93567
- URL: https://www.wjgnet.com/2220-3230/full/v14/i2/93567.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i2.93567